Abstract
We evaluated bone mineralization and metabolism changes related to vitamin D receptor (VDR) polymorphic genotypes in children with juvenile idiopathic arthritis. One hundred and ninety eight children (82 boys and 116 girls) were included in our study. Bone mineral density (BMD) was measured by lumbar spine DXA. Osteocalcin, CTX, parathyroid hormone, total and ionized calcium, inorganic phosphate, total alkaline phosphatase activity was utilized for assessment of bone metabolism. Molecular testing: TaqI (rs731236) and Cdx2 (rs11568820) polymorphisms of VDR were detected by RFLP. No differences in TaqI and Cdx2 haplotypes, genotypes and alleles distribution related with normal and low BMD (Zscore <−2SD) were found. Children with low linear growth (<10th percentile) had more allele T-contained genotypes of TagI VDR (p = 0.037), compare with medium or high linear growth children. Children with high linear growth (>90th percentile) had the highest frequency of allele A-contained genotypes (GA+AA) of Cdx2 VDR (p = 0.009). Girls with TT TaqI VDR, who never been treated by glucocorticoides had lower BMD-Zscore than C allele carriers (TT = −0.94SD [IQR: −2.1;−0.5], TC+CC = −0.62SD [IQR: −1.26;0.39], p = 0.03). Girls with Tanner I with TT had higher total and ionized Ca level than carriers of C allele (Ca: TT = 2.43 ± 0.15 mmol/l, TC+CC = 2.28 ± 0.2 mmol/l, p = 0.024; Ca2+: TT = 1.15 ± 0.08 mmol/l, TC+CC = 1.06 ± 0.13 mmol/l, p = 0.026). Presence of TT genotype negatively correlated with BMD-Zscore (r = −0.28, p = 0.04), and positively with frequency of LBMD (r = 0.3, p = 0.037). Boy with GG Cdx2 genotype had lower total Ca (GG = 2.3 ± 0.17 mmol/l, GA+AA = 2.43 ± 0.17 mmol/l, p = 0.004) compare with carriers of A allele. Pubertal boys (Tanner IV–V) with GG had higher CTX (GG = 1.75 ± 0.11 ng/ml, GA+AA = 1.06 ± 0.07 ng/ml, p = 0.04. TT genotype of TaqI and GG genotype of Cdx2 VDR is a negative factor impact bone mineralization metabolism and linear growth.
Similar content being viewed by others
References:
Pérez-López FR, Chedraui P, Cuadros-López JL (2010) Bone mass gain during puberty and adolescence: deconstructing gender characteristics. Curr Med Chem 17:453–466
Deal C (2012) Bone loss in rheumatoid arthritis: systemic, periarticular, and focal. Curr Rheumatol Rep 14:231–237
den Uyl D, Bultink IE, Lems WF (2011) Glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 29:S93–S98
Hämäläinen H, Arkela-Kautiainen M, Kautiainen H, Haapasaari J, Leirisalo-Repo M (2010) Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls. Scand J Rheumatol 39:219–222
Sušić G, Pilipović N, Stojanović R (2009) Bone mineral density in patients with juvenile idiopathic arthritis. Srp Arh Celok Lek 137:396–401
Lurati A, Cimaz R, Gattinara M, Gerloni V, Teruzzi B, Salmaso A, Fantini F (2008) Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis. Reumatismo 60:224–229
Pike JW, Zella LA, Meyer MB, Fretz JA, Kim S (2007) Molecular Actions of 1,25-dihydroxyvitamin D3 on genes involved in calcium homeostasis. J Bone Miner Res 22:16–19
Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38:3643–3651
Malerba G, Pignatti PF (2005) A review of asthma genetics: gene expression studies and recent candidates. J Appl Genet 46:93–104
Ramos-Lopez E, Jansen T, Ivaskevicius V, Kahles H, Klepzig C, Oldenburg J, Badenhoop K (2006) Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann NY Acad Sci 1079:327–334
San-Pedro JI, Bilbao JR, Perez de Nanclares G, Vitoria JC, Martul P, Castaño L (2005) Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity 38:439–444
Abrams SA, Griffin IJ, Hawthorne KM, Chen Z, Gunn SK, Wilde M, Darlington G, Shypailo RG, Ellis KJ (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20:945–953
Yamamoto H, Miyamoto K, Li Bailing, Taketani Y, Kitano M, Inoue Y, Morita K, Pike JW, Takeda E (1999) The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res 14:240–247
Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E (2001) The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 16:1256–1264
Macdonald HM, McGuigan FE, Stewart A, Black AJ, Fraser WD, Ralston S, Reid DM (2006) Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J Bone Miner Res 21:151–162
Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG (2003) Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18:1632–1641
Bryant RJ, Wastney ME, Martin BR, Wood O, McCabe GP, Morshidi M, Smith DL, Peacock M, Weaver CM (2003) Racial differences in bone turnover and calcium metabolism in adolescent females. J Clin Endocrinol Metab 88:1043–1047
Jakubowska-Pietkiewicz E, Młynarski W, Klich I, Fendler W, Chlebna-Sokół D (2012) Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients. Mol Biol Rep 39(5):6243–6250
Kocabaş A, Karagüzel G, Imir N, Yavuzer U, Akçurin S (2010) Effects of vitamin D receptor gene polymorphisms on susceptibility to disease and bone mineral density in Turkish patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 23:1289–1297
van der Sluis IM, de Muinck Keizer-Schrama SMPF, Krenning EP, Pols HAP, Uitterlinden AG (2003) Vitamin D receptor gene polymorphism predicts height and bone size, rather than bone density in children and young adults. Calcif Tissue Int 73:332–338
Cusack S, Mølgaard C, Michaelsen KF, Jakobsen J, Lamberg-Allardt CJE, Cashman KD (2006) Vitamin D and estrogen receptor-a genotype and indices of bone mass and bone turnover in Danish girls. J Bone Miner Metab 24:329–336
Macgregor S, Hottenga JJ, Lind PA, Suchiman HED, Willemsen G, Slagboom PE, Montgomery GW, Martin NG, Visscher PM, Boomsma DI (2008) Vitamin D receptor gene polymorphisms have negligible effect on human height. Twin Res Hum Gen 11:488–494
Gough A, Sambrook P, Devlin J, Lilley J, Huisoon A, Betteridge J, Franklyn J, Nguyen T, Morrison N, Eisman J, Emery P (1998) Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 25:864–868
Rass P, Pákozdi A, Lakatos P, Zilahi E, Sipka S, Szegedi G, Szekanecz Z (2006) Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 26:964–971
Goertz B, Fassbender WJ, Williams JC, Marzeion AM, Bretzel RG, Stracke H, Berliner MN (2003) Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol 21:333–339
Lee CK, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB (2001) Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci 16:188–192
Masi L, Cimaz R, Simonini G, Bindi G, Stagi S, Gozzini A, Malentacchi C, Brandi ML, Falcini F (2002) Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. J Rheumatol 29:2225–2231
Conflict of interests
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kostik, M.M., Smirnov, A.M., Demin, G.S. et al. Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism. Mol Biol Rep 41, 1937–1943 (2014). https://doi.org/10.1007/s11033-014-3040-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3040-x